No connection

Search Results

HIT

BEARISH
$1.34 Live
Health In Tech, Inc. · NASDAQ
Target $4.28 (+219.0%)
$0.55 52W Range $4.02

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 11, 2026
Market cap
$87.85M
P/E
67.0
ROE
8.4%
Profit margin
3.8%
Debt/Equity
0.01
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.

Key Strengths

Strong YoY and Q/Q revenue growth of ~53%
Negligible debt levels (Debt/Equity 0.01)
Robust liquidity with a Current Ratio of 3.13
Healthy Gross Margins at 62.82%
Positive ROE (8.45%) and ROA (4.92%)

Key Risks

Severe bearish technical trend (0/100 score)
Significant overvaluation relative to Graham and Intrinsic values
Negative operating margin (-2.28%) indicating operational inefficiency
Poor earnings reliability with 0/4 estimates beaten
Extreme price volatility with a 60.8% drop in 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$0.42
-68.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
34
Weak
Value
20
Future
65
Past
25
Health
60
Dividend
0
AI Verdict
Speculative/High Risk
Key drivers: Revenue growth, Balance sheet strength, Technical collapse, Valuation gap
Confidence
90%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
  • Low Forward P/E (7.24) suggests expected earnings jump
Watchpoints
  • Current P/E (67.00) is high
  • Price ($1.34) is ~3.6x the Graham Number ($0.37)
Future
65/100

Ref Growth rates

Positives
  • Consistent 53% revenue growth
  • Aggressive analyst target price of $4.28
Watchpoints
  • Recent Q/Q EPS growth crashed by -200%
Past
25/100

Ref Historical trends

Positives
  • 1Y return was positive (+107.8%)
Watchpoints
  • 5Y change is -73.7%
  • Recent 6M and 1M trends are sharply negative
Health
60/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Very low Debt/Equity
  • Strong Current and Quick ratios
Watchpoints
  • Piotroski F-Score is only 4/9
  • Operating margin is negative
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.34
Analyst Target
$4.28
Upside/Downside
+219.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HIT and closest competitors.

Updated 2026-04-10
HIT
Health In Tech, Inc.
Primary
5Y
-73.7%
3Y
-73.7%
1Y
+107.8%
6M
-60.8%
1M
-32.3%
1W
-6.9%
AIS
Airship AI Holdings, Inc.
Peer
5Y
-73.2%
3Y
-74.2%
1Y
-22.6%
6M
-51.6%
1M
+5.2%
1W
-0.8%
ARB
Arbe Robotics Ltd.
Peer
5Y
-92.4%
3Y
-76.5%
1Y
-32.9%
6M
-43.5%
1M
-33.5%
1W
-2.9%
GNS
Genasys Inc.
Peer
5Y
-75.4%
3Y
-37.5%
1Y
-12.2%
6M
-19.6%
1M
-0.6%
1W
-0.6%
EXF
Expensify, Inc.
Peer
5Y
-98.1%
3Y
-89.8%
1Y
-69.2%
6M
-53.9%
1M
-16.0%
1W
-8.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
67.0
Forward P/E
7.24
PEG Ratio
N/A
P/B Ratio
4.51
P/S Ratio
2.64
EV/Revenue
2.19
EV/EBITDA
29.98
Market Cap
$87.85M

Profitability

Profit margins and return metrics

Profit Margin 3.84%
Operating Margin -2.27%
Gross Margin 62.82%
ROE 8.45%
ROA 4.92%

Growth

Revenue and earnings growth rates

Revenue Growth +53.1%
Earnings Growth N/A
Q/Q Revenue Growth +53.09%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.01
Low debt
Current Ratio
3.13
Strong
Quick Ratio
2.31
Excellent
Cash/Share
$0.13

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
55.0%
Op. Margin
-2.3%
Net Margin
-4.0%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.35x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-84%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-20
$N/A
2026-03-25
$-0.01
2025-11-12
$0.01
2025-07-21
$0.01

Technology Sector Comparison

Comparing HIT against 235 companies in the Technology sector (20 bullish, 88 neutral, 127 bearish)
P/E Ratio
67.0
This Stock
vs
64.57
Sector Avg
+3.8% (Premium)
Return on Equity (ROE)
8.45%
This Stock
vs
-27.67%
Sector Avg
-130.5% (Below Avg)
Profit Margin
3.84%
This Stock
vs
-10.61%
Sector Avg
-136.2% (Weaker)
Debt to Equity
0.01
This Stock
vs
0.78
Sector Avg
-98.9% (Less Debt)
Revenue Growth
53.1%
This Stock
vs
10428.62%
Sector Avg
-99.5% (Slower)
Current Ratio
3.13
This Stock
vs
3.86
Sector Avg
-18.8% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

JOHNSON TIM DONALD
Chief Executive Officer
Stock Award
2026-01-06
1,000,000 shares
QIAN LINLIN
Chief Financial Officer
Stock Award
2026-01-06
1,000,000 shares
HASAN ZAIN SYED
Officer
Stock Award
2026-01-06
200,000 shares
CLARKSON MICHAEL DAVID
Chief Technology Officer
Stock Award
2025-11-05
8,000 shares
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning HIT from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile